EcoDrugPlus

Leukotriene B4 Receptor 1

Ensembl ID : ENSOKIG00005041206
Gene Symbol: LOC109875248
3 Cross references
161 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSOKIG00005006797
Gene Symbol: LOC109896917
2 Cross references
79 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSOKIG00005016122
Gene Symbol: LOC109871505
3 Cross references
161 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSOKIG00005006790
Gene Symbol: LOC109896914
2 Cross references
151 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSOKIG00005035342
Gene Symbol: LOC109906820
2 Cross references
151 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSOKIG00005003416
Gene Symbol: KDM1A
1 Cross references
205 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSOKIG00005009785
Gene Symbol: KDM1A
1 Cross references
207 Possible Orthologues:

Lysyl Oxidase Homolog 2a

Ensembl ID : ENSOKIG00005022902
Gene Symbol: LOC109893880
3 Cross references
204 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSOKIG00005000328
Gene Symbol: LOC109891247
3 Cross references
204 Possible Orthologues:

Lysyl Oxidase Homolog 2b

Ensembl ID : ENSOKIG00005012632
Gene Symbol: LOC109882399
3 Cross references
206 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSOKIG00005002528
Gene Symbol: LOXL2B
1 Cross references
206 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 1

Ensembl ID : ENSOKIG00005050227
Gene Symbol: LOC109873718
2 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).